Evidence map›Paper›PMID 41543560›Full record

ReviewHerzschrittmachertherapie & Elektrophysiologie2026

Supraventricular tachycardias in ion channel diseases.

Christian Wolpert, Gaetano Vacanti, Davit Ohanyan, Norman Rüb

Abstract readReview
PubMed Publisher
In one paragraph

Review in Herzschrittmachertherapie & Elektrophysiologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Christian Wolpert2nd Department of Internal Medicine-Cardiology, Nephrology and Intensive Care Medicine, Ludwigsburg Clinic, Posilipostrasse 4, 71640, Ludwigsburg, Germany. christian.wolpert@rkh-gesundheit.de.
Gaetano Vacanti2nd Department of Internal Medicine-Cardiology, Nephrology and Intensive Care Medicine, Ludwigsburg Clinic, Posilipostrasse 4, 71640, Ludwigsburg, Germany.
Davit Ohanyan2nd Department of Internal Medicine-Cardiology, Nephrology and Intensive Care Medicine, Ludwigsburg Clinic, Posilipostrasse 4, 71640, Ludwigsburg, Germany.
Norman Rüb2nd Department of Internal Medicine-Cardiology, Nephrology and Intensive Care Medicine, Ludwigsburg Clinic, Posilipostrasse 4, 71640, Ludwigsburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Supraventricular tachyarrhythmias are a clinical finding that is seen to a varying extent in patients with ion channel diseases depending on the underlying genetic disease. In addition to the classical symptoms that they cause, they may trigger ventricular tachyarrhythmias or induce inappropriate implantable cardioverter-defibrillator (ICD) therapies and, thus, cause psychological harm. Antiarrhythmic drugs can be used in some diseases, but are contraindicated in a number of genetic conditions. In these patients, catheter ablation is a good alternative and sometimes the only treatment choice. In young individuals with atrial fibrillation, ion channel diseases should be excluded, especially when there is familial disease or early onset of atrial fibrillation, in particular below 30 years of age.

Indexed as

Catheter AblationChannelopathiesTachycardia, SupraventricularAnti-Arrhythmia AgentsDefibrillators, ImplantableDiagnosis, DifferentialElectrocardiographyEvidence-Based MedicineGenetic Predisposition to DiseaseHumansTreatment OutcomeAnti-Arrhythmia AgentsAtrial fibrillationBrugada syndromeCatheter ablationImplantable defibrillatorInappropriate ICD discharges

Identifiers

PMID41543560

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.